The National Institute of Allergy & Infectious Diseases (NIAID) has founded a new clinical trials network focused on enrolling volunteers in clinical...
Sofinnova Partners – Venture capital firm Sofinnova Partners, one of Europe’s largest life sciences VC groups, announced the second investment from its...
MISSOULA, Mont., July 9, 2020 /PRNewswire/ -- Inimmune, www.inimmune.com, a biotechnology company developing immune therapies and components for more effective vaccines,...
The National Institute of Allergy & Infectious Diseases (NIAID) has founded a new clinical trials network focused on enrolling volunteers in clinical...
Osivax, a Lyon-based biotechnology company, secured €17.5M from the European Innovation Council and €15.1M from Bpifrance. The funding will be used to develop...
Remdesivir has received a one-year conditional marketing authorization from the European Commission due to the urgency of the Covid-19 pandemic, which has infected...
The Covid-19 pandemic has pushed vaccines and public health to the forefront of people’s minds. Investment and research in these areas have rocketed...
--Sharing is Caring-- Regeneron COVID19 Drug REGN-COV2 EntersFinal Stage Trials of Human TrialsThe American biotechnology company, Regeneron Pharmaceuticals has been investigating a drug...
--Sharing is Caring-- Treating COVID-19 Using ErythropoietinErythropoietin (Epo) is a drug for anemia. The doping agent, Epo can also be effective against COVID-19,...
As the Covid-19 pandemic sweeps the world, cancer research is proving a valuable resource for developing new treatments for infectious diseases by harnessing...
